Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years

Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease.  The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four … Read more

New blood pressure drug helps people with uncontrolled hypertension in trial

New blood pressure drug helps people with uncontrolled hypertension in trial

A new type of medication may help lower blood pressure in people with uncontrolled hypertension, researchers reported Saturday at the annual meeting of American College of Cardiology in Chicago. In a pivotal Phase 2b clinical trial, patients who took the experimental medication lorundrostat along with two or three currently available hypertension drugs saw a decrease in systolic … Read more

Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.

Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration answers a question during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., May 11, 2021. Greg Nash | Pool | Reuters … Read more

Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer

Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market. Eli Lilly plans to … Read more

Zepbound copycats remain online despite FDA ban

Zepbound copycats remain online despite FDA ban

This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly‘s weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn’t look like much has changed.  Popular websites like Amble, EllieMD, Willow and Mochi Health are all still advertising versions of tirzepatide, the active ingredient in Zepbound. Some, … Read more

White House pulls Trump CDC Director nominee Dave Weldon

White House pulls Trump CDC Director nominee Dave Weldon

Former Congressman Dave Weldon addresses a small crowd in The Villages, Fla. Brendan Farrington | AP The White House has pulled President Donald Trump’s nominee to lead the Centers for Disease Control and Prevention, former Rep. Dave Weldon, the Senate’s Health committee confirmed Thursday. The move came just hours before the former Florida lawmaker, a … Read more

RFK Jr. could further deter childhood vaccinations as U.S. rates fall

RFK Jr. could further deter childhood vaccinations as U.S. rates fall

Robert F. Kennedy Jr. speaks in the Oval Office of the White House, on the day he is sworn in as secretary of Health and Human Service in Washington, D.C., U.S., Feb. 13, 2025.  Nathan Howard | Reuters The nation’s new top health official could further erode already falling U.S. vaccination rates against once-common childhood … Read more

Walgreens to go private in $10 billion deal with Sycamore Partners

Walgreens to go private in  billion deal with Sycamore Partners

The Walgreens logo is displayed at a Walgreens store on October 15, 2024 in San Rafael, California.  Justin Sullivan | Getty Images Struggling drugstore chain Walgreens is going private.  The company on Thursday said it inked a deal with private equity firm Sycamore Partners that will take it off the public market for an equity … Read more

Novo Nordisk offers discounted Wegovy through direct-to-consumer pharmacy

Novo Nordisk offers discounted Wegovy through direct-to-consumer pharmacy

Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity.  Nurphoto | Getty Images Novo Nordisk on Wednesday said it will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy. The cash-pay offering is available to millions of patients … Read more

Amgen weight loss drug MariTide starts two phase three trials

Amgen weight loss drug MariTide starts two phase three trials

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market.  “We’re delighted to share … Read more